Respiratory function and blood gas variables in cystic fibrosis patients during reduced environmental pressure

Patients with cystic fibrosis (CF) suffer from hypoxaemia even under normobaric conditions and the reduction of inspiratory PO2 (O2 partial pressure) during air travel corresponding to an altitude of 1,800-2,450 m might be a problem for these patients. Ten CF patients and 27 healthy control subjects were investigated in a chamber where the ambient pressure was reduced to that found at 2,000 and 3,000 m. The respiratory function was reduced in the CF patients with a vital capacity of 3.1 (0.3) l [vs 4.9 (0.2) l in controls; mean (SEM)] and a forced expiratory 1-s volume of 2.1 (0.3) l [vs 4.3 (0.20 l in controls], unrelated to the reduction in ambient pressure. Mean arterial PO2 decreased from 75 (4) mmHg [85 (1) mmHg in controls, P<0.01] at sea level to 58 (3) mmHg at 580 mmHg and to 46 (1) mmHg [58 (1) mmHg and 49 (2) mmHg in controls, n.s.] at 513 mmHg ambient pressure. These results indicate that during air travel with a cabin pressure that corresponds to an altitude of 2,500 m, the arterial PO2 of CF patients is likely to remain above the accepted critical value of 50 mmHg. However, a further reduction of the pressure to that found at 3,000 m altitude may lead to severe hypoxia in patients with moderate airway obstruction.